These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6831473)
1. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans. Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473 [TBL] [Abstract][Full Text] [Related]
2. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products. Sasaki T; Abiko N; Sugino Y; Nitta K Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of antitumor activity and immunomodulatory effect of tetrahydro-2-furanyl and tetrahydro-2-pyranyl (1 leads to 3)-beta-D-glucans. Uchida H; Sasaki T J Pharmacobiodyn; 1983 Sep; 6(9):660-7. PubMed ID: 6655547 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140. Sasaki T; Abiko N; Nitta K; Takasuka N; Sugino Y Eur J Cancer (1965); 1979 Feb; 15(2):211-5. PubMed ID: 436898 [No Abstract] [Full Text] [Related]
5. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Morikawa K; Takeda R; Yamazaki M; Mizuno D Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669 [TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives. Honda S; Sugino H; Asano T; Kakinuma A Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648 [TBL] [Abstract][Full Text] [Related]
7. A cleavage product of mouse C3 adsorbable to (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140. Matsushita M; Sankawa U; Okuda T; Okada H; Sasaki T Jpn J Exp Med; 1983 Oct; 53(5):219-25. PubMed ID: 6206261 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of cell wall beta-1,3/1,6-glucans from Phytophthora species. Kraus J; Blaschek W; Schütz M; Franz G Planta Med; 1992 Feb; 58(1):39-42. PubMed ID: 1620741 [TBL] [Abstract][Full Text] [Related]
9. Molecular mass and antitumor activities of sulfated derivatives of alpha-glucan from Poria cocos mycelia. Lin Y; Zhang L; Chen L; Jin Y; Zeng F; Jin J; Wan B; Cheung PC Int J Biol Macromol; 2004 Oct; 34(5):289-94. PubMed ID: 15556230 [TBL] [Abstract][Full Text] [Related]
10. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Cheung NK; Modak S Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541 [TBL] [Abstract][Full Text] [Related]
11. Correlation of structure to antitumor activities of five derivatives of a beta-glucan from Poria cocos sclerotium. Wang Y; Zhang L; Li Y; Hou X; Zeng F Carbohydr Res; 2004 Oct; 339(15):2567-74. PubMed ID: 15476718 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395. Ohno N; Kurachi K; Yadomae T J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391 [TBL] [Abstract][Full Text] [Related]
13. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan. Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406 [TBL] [Abstract][Full Text] [Related]
15. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice. Oshiman K; Fujimiya Y; Ebina T; Suzuki I; Noji M Planta Med; 2002 Jul; 68(7):610-4. PubMed ID: 12142994 [TBL] [Abstract][Full Text] [Related]
16. Structure of pestalotan, a highly branched (1----3)-beta-D-glucan elaborated by Pestalotia sp. 815, and the enhancement of its antitumor activity by polyol modification of the side chains. Misaki A; Kawaguchi K; Miyaji H; Nagae H; Hokkoku S; Kakuta M; Sasaki T Carbohydr Res; 1984 Jul; 129():209-27. PubMed ID: 6547877 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activities of mitomycin C (1----3)-beta-D-glucan conjugate. Nagai K; Tanaka J; Kiho T; Ukai S Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):986-9. PubMed ID: 1525956 [TBL] [Abstract][Full Text] [Related]
18. Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice. Gorecka-Tisera A; Proctor JW; Yamamura Y; Harnaha J; Meinert K J Natl Cancer Inst; 1981 Oct; 67(4):911-5. PubMed ID: 6944557 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of beta-D-glucan from Libyan dates. Ishurd O; Zgheel F; Kermagi A; Flefla M; Elmabruk M J Med Food; 2004; 7(2):252-5. PubMed ID: 15298775 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of (1-->3)-beta-D-glucan in mice. Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]